SPHERES: innovative registry addressing the new era of neuromyelitis optica spectrum disorders (NMOSD) therapy

By sjmartinez • December 26, 2025

Bennett JL, Middaugh N, Yeaman MR, Smith TJ, Behne MK, Crabtree M, McLean RR, Pappas DA, Levy M. SPHERES: innovative registry addressing the new era of neuromyelitis optica spectrum disorders (NMOSD) therapy. Mult Scler Relat Disord. 2025 Dec 19;107:106940. doi: 10.1016/j.msard.2025.106940. Epub ahead of print. PMID: 41447909.

Tags: Disease activity measures, Guthy-Jackson Charitable Foundation, Harbor UCLA, Infectious Diseases, neuromyelitis optica spectrum disorders, nmosd, Patient reported outcomes, PROs, prospective observational cohort, Publications, real-world data, SPHERES registry

Sex-Specific Coronary Plaque Characteristics and Risk of Cardiovascular Events: Insights from ISCHEMIA

Lakshmanan S, Wang Y, Chen YQ, Mancini GJ, Leipsic J, Budoff M, Hague C, Min JK, Stone GW, Boden WE, Spertus JA, Bangalore S, Hochman[...]

MUCOR-ADVANCE: Uniting multidisciplinary science to defeat a deadly fungus

Wurster S, Stewart AG, Gu Y, Youssef EG, John TM, Uppuluri P, Chamilos G, Filler S, Bruno V, Ibrahim AS, Kontoyiannis DP; MUCOR-ADVANCE consortium. MUCOR-ADVANCE:[...]

Greener Prescribing: A Quasi-Experimental Study of the Environmental Impact of Metronidazole Dosing Interval Optimization

Alsoubani M, Campion M, Swarup S, Lee P, Pearl A, Foong KS. Greener Prescribing: A Quasi-Experimental Study of the Environmental Impact of Metronidazole Dosing Interval[...]